Measuring health-related quality-of-life for Alzheimer's disease using the general public
- PMID: 21744032
- DOI: 10.1007/s11136-011-9966-8
Measuring health-related quality-of-life for Alzheimer's disease using the general public
Abstract
Purpose: Little research exists to indicate whether the general public can provide proxy health-related quality-of-life (HRQoL) estimates for persons with Alzheimer's disease (AD). We investigated (1) whether the general public can differentiate between mild, moderate, and severe AD and (2) whether the general public's proxy HRQoL estimates are correlated with current health status.
Methods: We conducted computer-assisted personal interviews. The computer randomly assigned each participant to read a vignette describing mild, moderate, or severe AD. Participants answered the EQ-5D-5L and Quality-of-life-Alzheimer's Disease (QoL-AD), while imagining living in the health state described in their assigned vignette. Participants also answered the EQ-5D-5L based on their health state at the time of the interview.
Results: We interviewed 100 participants. EQ-5D-5L utilities were 0.7413 (mild), 0.6159 (moderate), and 0.4456 (severe) (P < 0.001). Mean QoL-AD scores were 32.5 (mild), 24.0 (moderate), and 21.8 (severe) (P < 0.0001 for severe vs. mild, moderate vs. mild; P > 0.05 for severe vs. moderate). Participants' EQ-5D-5L utility scores were weakly correlated (r ≤ 0.28) across both administrations of the instrument.
Conclusions: The general public can differentiate between the three stages of AD, and their HRQoL estimates for AD are weakly correlated with their current health status.
Similar articles
-
Can the general public use vignettes to discriminate between Alzheimer's disease health states?BMC Geriatr. 2016 Feb 3;16:36. doi: 10.1186/s12877-016-0207-4. BMC Geriatr. 2016. PMID: 26842500 Free PMC article.
-
How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.Value Health. 2019 Dec;22(12):1417-1426. doi: 10.1016/j.jval.2019.07.002. Epub 2019 Aug 26. Value Health. 2019. PMID: 31806199
-
Utility-based Quality of Life measures in Alzheimer's disease.Qual Life Res. 2006 May;15(4):631-43. doi: 10.1007/s11136-005-4364-8. Qual Life Res. 2006. PMID: 16688496 Clinical Trial.
-
Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.Value Health. 2015 Jul;18(5):638-45. doi: 10.1016/j.jval.2015.03.1787. Epub 2015 Apr 10. Value Health. 2015. PMID: 26297092 Clinical Trial.
-
Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.Alzheimers Res Ther. 2020 Nov 18;12(1):154. doi: 10.1186/s13195-020-00723-1. Alzheimers Res Ther. 2020. PMID: 33208190 Free PMC article.
Cited by
-
Can the general public use vignettes to discriminate between Alzheimer's disease health states?BMC Geriatr. 2016 Feb 3;16:36. doi: 10.1186/s12877-016-0207-4. BMC Geriatr. 2016. PMID: 26842500 Free PMC article.
-
Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study.PLoS One. 2016 Sep 2;11(9):e0162422. doi: 10.1371/journal.pone.0162422. eCollection 2016. PLoS One. 2016. PMID: 27589604 Free PMC article.
-
Identifying the components of clinical vignettes describing Alzheimer's disease or other dementias: a scoping review.BMC Med Inform Decis Mak. 2015 Jul 15;15:54. doi: 10.1186/s12911-015-0179-x. BMC Med Inform Decis Mak. 2015. PMID: 26174660 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical